Solomon Moshkevich - Jan 24, 2024 Form 3 Insider Report for Natera, Inc. (NTRA)

Role
President, ClinicalDiagnostics
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
3
Date filed
1/30/2024, 09:01 PM
Next filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NTRA Common Stock 167K Jan 24, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 5.75K $7.45 Direct F3
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 3.32K $12.85 Direct F3
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 27.5K $9.59 Direct F3
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 42.5K $10.41 Direct F3
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 20K $9.29 Direct F3
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 5.93K $15.57 Direct F3
holding NTRA Stock Option (right to buy) Jan 24, 2024 Common Stock 34K $19.68 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (a) 82,816 shares of common stock held by the Reporting Person, (b) 1,375 shares subject to the Reporting Person's March 27, 2020 restricted stock unit ("RSU") grant that will vest in successive equal quarterly installments through March 27, 2024, (c) 2,004 shares subject to the Reporting Person's January 22, 2021 RSU grant that will vest in successive equal quarterly installments through January 21, 2025, (d) 4,566 shares subject to the Reporting Person's January 28, 2022 RSU grant that will vest in successive equal quarterly installments through January 20, 2026,
F2 (continued from footnote 1) (e) 9,619 shares subject to the Reporting Person's June 10, 2022 RSU grant that will vest in successive equal annual installments through May 25, 2026, (f) 37,248 shares subject to the Reporting Person's January 27, 2023 RSU grant that will vest in successive equal quarterly installments through January 27, 2027, and (g) 29,423 shares subject to the Reporting Person's August 25, 2023 RSU grant that will vest full on September 1, 2026. The vesting of all such RSU grants is subject to the Reporting Person's continuous Service (as defined in the Issuer's Equity Incentive Plan, (the "2015 EIP")) through each such date and subject to acceleration as provided in the 2015 EIP.
F3 The options are fully vested.